Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Menorrhagia × Medroxyprogesterone Acetate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Menorrhagia 1 Leiomyoma 1 Endometrial Neoplasms 1 Adenocarcinoma 1

Interventions

estradiol, norethindrone drug combination 6 elagolix 6 asoprisnil 6 Estradiol 5 vilaprisan 4 Norethindrone Acetate 4 relugolix 3 Uterine Myomectomy 3 linzagolix 2 Uterine Artery Embolization 2 ulipristal 1 Radiofrequency Ablation 1 Megestrol Acetate 1 Medroxyprogesterone Acetate 1 Electrocoagulation 1 Cryosurgery 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06671548 2026-02-02

Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

Qilu Pharmaceutical Co., Ltd.

Phase 3 Recruiting

Leiomyoma, Menorrhagia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡